These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 26270480)
1. Selamectin Is the Avermectin with the Best Potential for Buruli Ulcer Treatment. Scherr N; Pluschke G; Thompson CJ; Ramón-García S PLoS Negl Trop Dis; 2015 Aug; 9(8):e0003996. PubMed ID: 26270480 [TBL] [Abstract][Full Text] [Related]
2. In-vitro activity of avermectins against Mycobacterium ulcerans. Omansen TF; Porter JL; Johnson PD; van der Werf TS; Stienstra Y; Stinear TP PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003549. PubMed ID: 25742173 [TBL] [Abstract][Full Text] [Related]
4. The compound TB47 is highly bactericidal against Mycobacterium ulcerans in a Buruli ulcer mouse model. Liu Y; Gao Y; Liu J; Tan Y; Liu Z; Chhotaray C; Jiang H; Lu Z; Chiwala G; Wang S; Makafe G; Islam MM; Hameed HMA; Cai X; Wang C; Li X; Tan S; Zhang T Nat Commun; 2019 Jan; 10(1):524. PubMed ID: 30705268 [TBL] [Abstract][Full Text] [Related]
5. In vitro antibacterial activity and in vivo efficacy of hydrated clays on Mycobacterium ulcerans growth. Adusumilli S; Haydel SE BMC Complement Altern Med; 2016 Jan; 16():40. PubMed ID: 26833071 [TBL] [Abstract][Full Text] [Related]
6. Buruli ulcer: a review of in vitro tests to screen natural products for activity against Mycobacterium ulcerans. Yemoa A; Gbenou J; Affolabi D; Moudachirou M; Bigot A; Anagonou S; Portaels F; Quetin-Leclercq J; Martin A Planta Med; 2011 Apr; 77(6):641-6. PubMed ID: 21240839 [TBL] [Abstract][Full Text] [Related]
8. Triple oral beta-lactam containing therapy for Buruli ulcer treatment shortening. Arenaz-Callao MP; González Del Río R; Lucía Quintana A; Thompson CJ; Mendoza-Losana A; Ramón-García S PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007126. PubMed ID: 30689630 [TBL] [Abstract][Full Text] [Related]
9. Telacebec (Q203)-containing intermittent oral regimens sterilized mice infected with Mycobacterium ulcerans after only 16 doses. Chauffour A; Robert J; Veziris N; Aubry A; Pethe K; Jarlier V PLoS Negl Trop Dis; 2020 Aug; 14(8):e0007857. PubMed ID: 32866170 [TBL] [Abstract][Full Text] [Related]
10. In Vitro Activity of Selected West African Medicinal Plants against Mycobacterium ulcerans Disease. Tsouh Fokou PV; Kissi-Twum AA; Yeboah-Manu D; Appiah-Opong R; Addo P; Tchokouaha Yamthe LR; Ngoutane Mfopa A; Fekam Boyom F; Nyarko AK Molecules; 2016 Apr; 21(4):445. PubMed ID: 27089314 [TBL] [Abstract][Full Text] [Related]
11. The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the Ezquerra-Aznárez JM; Degiacomi G; Gašparovič H; Stelitano G; Sammartino JC; Korduláková J; Governa P; Manetti F; Pasca MR; Chiarelli LR; Ramón-García S Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054958 [TBL] [Abstract][Full Text] [Related]
12. Repurposing Avermectins and Milbemycins against Muñoz-Muñoz L; Shoen C; Sweet G; Vitoria A; Bull TJ; Cynamon M; Thompson CJ; Ramón-García S Antibiotics (Basel); 2021 Apr; 10(4):. PubMed ID: 33916775 [TBL] [Abstract][Full Text] [Related]
13. Targeting the Mycobacterium ulcerans cytochrome bc Scherr N; Bieri R; Thomas SS; Chauffour A; Kalia NP; Schneide P; Ruf MT; Lamelas A; Manimekalai MSS; Grüber G; Ishii N; Suzuki K; Tanner M; Moraski GC; Miller MJ; Witschel M; Jarlier V; Pluschke G; Pethe K Nat Commun; 2018 Dec; 9(1):5370. PubMed ID: 30560872 [TBL] [Abstract][Full Text] [Related]
14. History of avermectin and ivermectin, with notes on the history of other macrocyclic lactone antiparasitic agents. Campbell WC Curr Pharm Biotechnol; 2012 May; 13(6):853-65. PubMed ID: 22039784 [TBL] [Abstract][Full Text] [Related]
15. Rapid, serial, non-invasive assessment of drug efficacy in mice with autoluminescent Mycobacterium ulcerans infection. Zhang T; Li SY; Converse PJ; Grosset JH; Nuermberger EL PLoS Negl Trop Dis; 2013; 7(12):e2598. PubMed ID: 24367713 [TBL] [Abstract][Full Text] [Related]
16. Phenotypic Profiling of Macrocyclic Lactones on Parasitic Ryan KT; Wheeler NJ; Kamara IK; Johnson H; Humphries JE; Zamanian M; Chan JD Antimicrob Agents Chemother; 2023 Feb; 67(2):e0123022. PubMed ID: 36695583 [TBL] [Abstract][Full Text] [Related]
17. Evaluating decontamination protocols for the isolation of Mycobacterium ulcerans from swabs. Owusu E; Newman MJ; Akumwena A; Bannerman E; Pluschke G BMC Microbiol; 2017 Jan; 17(1):2. PubMed ID: 28056807 [TBL] [Abstract][Full Text] [Related]
18. Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife? Converse PJ; Nuermberger EL; Almeida DV; Grosset JH Future Microbiol; 2011 Oct; 6(10):1185-98. PubMed ID: 22004037 [TBL] [Abstract][Full Text] [Related]
19. Molecular Informatics Studies of the Iron-Dependent Regulator (ideR) Reveal Potential Novel Anti- Kwofie SK; Enninful KS; Yussif JA; Asante LA; Adjei M; Kan-Dapaah K; Tiburu EK; Mensah WA; Miller WA; Mosi L; Wilson MD Molecules; 2019 Jun; 24(12):. PubMed ID: 31234337 [TBL] [Abstract][Full Text] [Related]
20. Buruli ulcer in West Africa: strategies for early detection and treatment in the antibiotic era. Webb BJ; Hauck FR; Houp E; Portaels F East Afr J Public Health; 2009 Aug; 6(2):144-7. PubMed ID: 20000019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]